Mirum Pharmaceuticals (mirm 4 05/01/29)
13F holders, Q2 2026 (June 30)2holders −2
0new positions
2sold out
$3.70avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Mirum Pharmaceuticals (mirm 4 05/01/29) in their 13F filings, down 2 from Q1 2026. 0 opened new positions and 2 sold out. The largest holders were Oppenheimer Asset Management Inc. ($229K) and Stephens Inc. ($74K).
- Company
- Mirum Pharmaceuticals (mirm 4 05/01/29)
- CUSIP
- 604749AB7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $10.4M |
All 13F filers, Q1 2026 → Q2 2026: 3,484,000 shares sold, net −3,484,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -1.6% | 62,000 | $229K |
| Stephens Inc. | 0.00% | No change | 20,000 | $74K |
"% of holder's portfolio" is MIRUM PHARMACEUTICALS (MIRM 4 05/01/29)'s weight in each manager's 13F, not the share of Mirum Pharmaceuticals (mirm 4 05/01/29) the manager owns.